Logo image of XRAY

DENTSPLY SIRONA INC (XRAY) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:XRAY - US24906P1093 - Common Stock

11.29 USD
+0.2 (+1.8%)
Last: 11/26/2025, 8:09:47 PM
11.35 USD
+0.06 (+0.53%)
After Hours: 11/26/2025, 8:09:47 PM

XRAY Key Statistics, Chart & Performance

Key Statistics
Market Cap2.25B
Revenue(TTM)3.62B
Net Income(TTM)-882.00M
Shares199.48M
Float198.69M
52 Week High20.6
52 Week Low9.85
Yearly Dividend0.62
Dividend Yield4.91%
EPS(TTM)1.58
PE7.15
Fwd PE5.48
Earnings (Next)02-25 2026-02-25/amc
IPO1987-08-12
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies


XRAY short term performance overview.The bars show the price performance of XRAY in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 -20

XRAY long term performance overview.The bars show the price performance of XRAY in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of XRAY is 11.29 USD. In the past month the price decreased by -12.21%. In the past year, price decreased by -42.54%.

DENTSPLY SIRONA INC / XRAY Daily stock chart

XRAY Latest News, Press Relases and Analysis

XRAY Competitors/Peers

The largest stocks on the US markets in the "Health Care Supplies" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
COO COOPER COS INC/THE 19.39 15.50B
SOLV SOLVENTUM CORP 14.36 14.78B
ALGN ALIGN TECHNOLOGY INC 15.23 10.67B
MMSI MERIT MEDICAL SYSTEMS INC 23.5 5.18B
LNTH LANTHEUS HOLDINGS INC 9.86 3.99B
HAE HAEMONETICS CORP/MASS 16.82 3.89B
ICUI ICU MEDICAL INC 18.74 3.68B
UFPT UFP TECHNOLOGIES INC 26.03 1.73B
NEOG NEOGEN CORP 20.13 1.31B
STAA STAAR SURGICAL CO N/A 1.28B
EMBC EMBECTA CORP 4.23 735.22M
BVS BIOVENTUS INC - A 12.97 632.50M

About XRAY

Company Profile

XRAY logo image Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. The company is headquartered in Charlotte, North Carolina and currently employs 14,000 full-time employees. The company develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices. Its Connected Technology Solutions segment includes design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of its value-added endodontic, restorative, and preventive consumable products and small equipment used by dental professionals for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and dental professional-directed aligner solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for urinary and bowel management.

Company Info

DENTSPLY SIRONA INC

13320 Ballantyne Corporate Place

Charlotte NORTH CAROLINA 28277 US

CEO: Donald M. Casey

Employees: 14000

XRAY Company Website

XRAY Investor Relations

Phone: 18445463722

DENTSPLY SIRONA INC / XRAY FAQ

Can you describe the business of DENTSPLY SIRONA INC?

Dentsply Sirona, Inc. engages in the design, manufacture, sales and distribution of professional dental products and technologies. The company is headquartered in Charlotte, North Carolina and currently employs 14,000 full-time employees. The company develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices. Its Connected Technology Solutions segment includes design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of its value-added endodontic, restorative, and preventive consumable products and small equipment used by dental professionals for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and dental professional-directed aligner solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for urinary and bowel management.


Can you provide the latest stock price for DENTSPLY SIRONA INC?

The current stock price of XRAY is 11.29 USD. The price increased by 1.8% in the last trading session.


Does DENTSPLY SIRONA INC pay dividends?

DENTSPLY SIRONA INC (XRAY) has a dividend yield of 4.91%. The yearly dividend amount is currently 0.62.


How is the ChartMill rating for DENTSPLY SIRONA INC?

XRAY has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


How is the market expecting XRAY stock to perform?

22 analysts have analysed XRAY and the average price target is 12.99 USD. This implies a price increase of 15.02% is expected in the next year compared to the current price of 11.29.


What is the market capitalization of XRAY stock?

DENTSPLY SIRONA INC (XRAY) has a market capitalization of 2.25B USD. This makes XRAY a Mid Cap stock.


Who owns DENTSPLY SIRONA INC?

You can find the ownership structure of DENTSPLY SIRONA INC (XRAY) on the Ownership tab.


XRAY Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

XRAY Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to XRAY. There are concerns on the financial health of XRAY while its profitability can be described as average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

XRAY Financial Highlights

Over the last trailing twelve months XRAY reported a non-GAAP Earnings per Share(EPS) of 1.58. The EPS decreased by -14.59% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -15.6%
ROE -59.68%
Debt/Equity 1.36
Chartmill High Growth Momentum
EPS Q2Q%-26%
Sales Q2Q%-4.94%
EPS 1Y (TTM)-14.59%
Revenue 1Y (TTM)-7.08%

XRAY Forecast & Estimates

22 analysts have analysed XRAY and the average price target is 12.99 USD. This implies a price increase of 15.02% is expected in the next year compared to the current price of 11.29.

For the next year, analysts expect an EPS growth of 14.71% and a revenue growth -4.07% for XRAY


Analysts
Analysts70.91
Price Target12.99 (15.06%)
EPS Next Y14.71%
Revenue Next Year-4.07%

XRAY Ownership

Ownership
Inst Owners104.22%
Ins Owners0.32%
Short Float %5.26%
Short Ratio2.93